Actively Recruiting

Phase Not Applicable
Age: 21Years +
All Genders
ID07248202

A Comparison of Ketamine-Lidocaine Versus Ketamine-Fentanyl for Anesthesia Induction Impact on Brain Blood Flow in Patients with Coronary Artery Disease and Left Ventricular Dysfunction Undergoing Elective Coronary Artery Bypass Surgery

Led by Cairo University · Updated on 2026-03-17

40

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are comparing two anesthesia induction methods using ketamine combined with either fentanyl or lidocaine to see how they affect brain blood flow in patients with coronary artery disease and significant left ventricular dysfunction undergoing planned coronary artery bypass graft surgery. This study aims to find which induction approach better maintains brain oxygen levels, as no previous data exists on these effects. Participants will receive ketamine slowly until they lose consciousness, followed by either a fentanyl bolus or a lidocaine bolus depending on their group. Afterward, anesthesia will be maintained with isoflurane and oxygen/air, with careful monitoring and treatment for any heart rate or blood pressure changes. Brain oxygen levels will be monitored continuously with near-infrared spectroscopy (NIRS) and other monitoring devices during and after induction. During the study, participants will be assessed for brain oxygenation every few minutes for 20 minutes following anesthesia induction, along with heart rate and blood pressure monitoring. Researchers will also track any episodes of low blood pressure, need for extra fentanyl doses, and postoperative complications such as heart attack, stroke, kidney injury, wound infection, or dialysis within 30 days after surgery. The study will last from December 2025 to July 2026.

CONDITIONS

Brief Title

Ketamine-lidocaine Versus Ketamine-fentanyl for Induction of Anesthesia in Patients With Left Ventricular Systolic Dysfunction Undergoing Elective Coronary Artery Bypass

Who Can Participate

Age: 21Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with coronary artery disease
  • Moderate to severe left ventricular dysfunction with ejection fraction less than 40%
  • Scheduled for elective coronary artery bypass graft surgery
  • Adults aged 21 years or older
Not Eligible

You will not qualify if you...

  • History of chronic stroke, transient ischemic attack, or carotid occlusive disease
  • Known neurological impairment such as cerebral infarction or dementia
  • Significant carotid artery stenosis
  • Valvular heart disease
  • Persistent arrhythmias
  • Congestive cardiac failure
  • On mechanical ventilation
  • Using intra-aortic balloon pump
  • Emergency surgery
  • Known allergy to any study drugs
  • Severe systemic non-cardiac disease
  • Baseline near-infrared spectroscopy (NIRS) reading less than 60%
  • Dementia or visual or auditory impairment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Duration of anesthesia induction and up to 20 minutes afterward

Participants receive anesthesia induction with either ketamine-lidocaine or ketamine-fentanyl before elective coronary artery bypass surgery. Various monitoring procedures including cerebral oximetry and heart rate are performed during and shortly after anesthesia induction.

Continuous monitoring during induction and for 20 minutes post-induction

Post-operative Follow-up

Duration - 30 days after surgery

Participants are monitored for postoperative complications including myocardial infarction, stroke, acute kidney injury, wound infection, and need for renal replacement therapy for 30 days after extubation.

Follow-up visits or assessments as part of postoperative care

Trial Site Locations

Total: 1 location

1

Kasr Alainy Hospital

Cairo, Egypt, 11562

Actively Recruiting

Loading map...

Research Team

M

Maha Mostafa

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

Erectile Function After Percutaneous Coronary Intervention i...

Erectile Disfunction

Actively Recruiting

1 location

A Phase 2a Randomized, Double-Blind, Placebo-Controlled, Seq...

Coronary Artery Disease (CAD)

Actively Recruiting

1 location

AI Facial Analysis Algorithm to Screening Coronary Artery Di...

Coronary Artery Disease (CAD)

Actively Recruiting

3 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here